Jump to content
PC Security Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE

Blogs

Drug repurposing service providers market is projected to grow at an annualized rate of 14.7% / till 2030

Roots Analysis has done a detailed study on Drug Repurposing Service Providers Market, 2020-2030.” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 250+ page report, which features 100+ figures and 140+ tables, please visit this https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html   Key Market Insights §  More than 60 industry players across the world are presently engage

Drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030 / Roots Analysis

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs   Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.”   The report features an extensive study of the current market landscape and future opportunities

“Global Collaborative Robots (Cobots) Market, 2020-2030” / By Roots Analysis

To order this detailed 245+ page report, please visit this https://www.rootsanalysis.com/reports/collaborative-robots-market.html     Key Inclusions §  An overview of the current market landscape of cobots, providing information on the market availability (available and under development), industrial task(s) performed (air blowing / spraying, CNC machine tending, gluing / dispensing / welding, loading / unloading, material handling, material removal / processing, packaging, palle

Over 230 cobots, having variable payload capacities and degrees of freedom / Roots Analysis

Collaborative robots or cobots allow companies to automate their processes, are easy to program and deploy, can increase productivity manifolds, and offer high returns on investment. It is worth noting that, according to the International Federation of Robotics (IFR), over time, the cost of cobots has decreased owing to growing demand for such machines across various industries, including automobiles, electronics / electrical goods, food and beverages, as well as life sciences / pharmaceuticals.

Global collaborative robots to grow at an annualized rate of 34.4% / till 2030

Roots Analysis has done a detailed study on Global Collaborative Robots (Cobots) Market, 2020-2030.” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 245+ page report, which features 80+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/collaborative-robots-market.html      Key Market Insights §  Several players are currently engaged in the deve

Global collaborative robots (cobots) market is projected growing at a CAGR of 34.4% / Roots Analysis

Given their flexibility and price to functionality ratio, cobots represent an ideal entry-level, automation model for both small and established companies, which do not intend to make very heavy large investments in automation   Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Collaborative Robots (Cobots) Market, 2020-2030.”   The report features an extensive study of the potential applications, current landscape and the likely adopt

Cell Therapy Manufacturing Market (3rd Edition), 2019-2030 / By Roots Analysis

To order this 550+ page report, please visit this https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html   Key Inclusions §  A detailed review of the overall landscape of companies that are engaged in the manufacturing of cell-based therapies, including information on the type of cells manufactured (including immune cells (including T cells, dendritic cells, NK cells), stem cells (including adult stem cells, human embryonic stem cells and induced p

More than 100 industry players and over 60 non-industry players currently / By Roots Analysis

Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key enabler within the cell therapy manufacturing and contract services industry   To order this 550+ page report, which features 160+ figures and 250+ tables, please visit this https://www.rootsan

Cell therapy manufacturing market is projected to grow at an annualized rate of >16.5% / till 2030

Roots Analysis has done a detailed study on Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030, covering various important aspects of the industry and identifying key future growth opportunities.   To order this 550+ page report, which features 160+ figures and 250+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html   Key Market Insights §  More than 100 industry players and over 60 non-industry pl

Cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030 / Roots Analysis

Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers   Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030”   The report features an extensive study of the current market landscape and future opportunities

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market / Roots Analysis

The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity   Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030” report to its list of offerings.   Owing to various reasons, the demand for cell therapies is anticipated to increase ove

Global Autoinjectors Market (3rd Edition), 2020-2030 / By Roots Analysis

To order this detailed 600+ page report, please visit this https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html   Key Inclusions §  An overview of the current market landscape of companies engaged in developing and / or manufacturing autoinjectors, providing information on the usability (disposable and reusable), type of primary drug container (cartridge, syringe and vial), volume of container, type of dose (fixed and variable), route of administration

Several companies claim to be engaged in the development / manufacturing of various types of autoinjectors / claims Roots Analysis

In addition to enabling patients to self-medicate, these devices are designed to ensure safety during the dosing process and promote compliance to prescribed therapeutic regimens. Moreover, the adoption of autoinjectors, and other self-injection products, has enabled significant cost savings for end users by eliminating the need to visit hospitals / out-patient clinics for dosing.   To order this 600+ page report, which features 360+ figures and 350+ tables, please visit this https://

Global autoinjectors market is projected to grow at an annualized rate of ~10%, till 2030 / By Roots Analysis

Roots Analysis has done a detailed study on Global Autoinjectors Market (3rd Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 600+ page report, which features 360+ figures and 350+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html   Key Market Insights §  Currently, several companies claim to be engaged in the development

Global autoinjectors market is projected to grow at an annualized rate of over 10% / till 2030

Autoinjectors have become an important part of modern healthcare, having demonstrated the potential to address a number of parenteral drug delivery related adverse events, and improve medication adherence among patients   Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Autoinjectors Market (3rd Edition), 2020-2030.”   The report features an extensive study of the current market landscape, offering an informed opinion on

“Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030”

To order this 350+ page report, please visit this https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html   Key Inclusions §  A detailed review of the overall landscape of the non-invasive cancer diagnostics market, featuring information on the developers of such products and analyses based on a number of relevant parameters, such as year of establishment, company size, geographical location, current development status of proprietary liquid biops

Nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers, By Roots Analysis

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.   To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this link   The financial opportunity within the liquid biopsy and other non-invasive cancer diagnostics market has been analyzed across th

Non-invasive cancer diagnostics market is projected to grow at an annualized rate of ~20%, till 2030

Roots Analysis has done a detailed study on Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers.” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/liquid-

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, By Roots Analysis

Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access   Roots Analysis is pleased to announce the publication of its recent study, titled, “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes an

“Live Biotherapeutic Products and Microbiome Contract Manufacturing Market” By Rootsa Analysis

To order this detailed 300+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html   Key Inclusions §  An assessment of microbiome contract manufacturing capability in different regions, based on a number of relevant parameters, such as number of CMOs, number of completed / active / planned clinical trials, number of patients enrolled, number of manufacturing facilities, number of companies offering API / FDF

Microbiome therapies pipeline features 260 drugs under evaluation across different phases of development, By Roots Analysis

Manufacturing live biotherapeutic products is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.   To order this 300+ page report, which features 140+ figures and 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html   The USD 300 mil

For live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, By Roots Analysis

Roots Analysis has done a detailed study on Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 300+ page report, which features 140+ figures and 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/microbiome-contrac

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, By Roots Analysis

Manufacturing live biotherapeutic product is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.   Roots Analysis is pleased to announce the publication of its recent study, titled, “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage
×
  • Create New...